A scientific panel that shaped the federal government’s policy for testing the safety and effectiveness of painkillers was funded by major pharmaceutical companies that paid hundreds of thousands of dollars for the chance to affect the thinking of the Food and Drug Administration, according to hundreds of e-mails obtained by a public records request.
The e-mails show that the companies paid as much as $25,000 to attend any given meeting of the panel, which had been set up by two academics to provide advice to the FDA on how to weigh the evidence from clinical trials. A leading FDA official later called the group “an essential collaborative effort.”
Patient advocacy groups said the electronic communications suggest that the regulators had become too close to the companies trying to crack into the $9 billion painkiller market in the United States. FDA officials who regulate painkillers sat on the steering committee of the panel, which met in private, and co-wrote papers with employees of pharmaceutical companies.
The FDA has been criticized for failing to take precautions that might have averted the epidemic of addiction to prescription drugs including Oxycontin and other opioids.
OTHER RECENT RELATED NEWS:
- Big Bucks, Big Pharma: Marketing Disease and Pushing Drugs (Documentary)
- Obamacare: Welcome to the New Face of Big Pharma (Ad Week)
- Even Huge $11 Billion Fines Don’t Stop Big Pharma (Natural Society)
- DSM-5 Criticized for Financial Conflicts of Interest (ABC)
- The Psychiatric Drug Crisis (New Yorker)
- Obama Administration, Congress Intensify Opposition To Global Generic Drug Industry (Huffington Post)
- Dr. Ben Goldacre’s Big Pharma News Section (Bad Science)
- Industry Fights Maine’s Prescription Drug Law (Courthouse News)
- Doctors ‘offered bribes for referrals to private firms’ (Telegraph)
- Novartis Accused of Paying China Doctors Kickbacks, Herald Says (Bloomberg)
- Deaths from painkiller overdose surge to record (Reuters)
- The FDA Did Not Do Enough to Restrict Antibiotics Use in Animals (The Atlantic)
- For Heart Patients, Exercise as Good as Drugs (Newser)
- Pro Publica Report: Tylenol can lead to liver failure, death (RT)
- Pets and Prozac (My Fox NY)
- Doc financial interest may influence MRI referrals (Reuters)